NCT00536965 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets Status COMPLETED Phase N/A
NCT00536913 Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma Status COMPLETED Phase PHASE3
NCT00536796 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets Status COMPLETED Phase N/A
NCT00536107 Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE4
NCT00535353 AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00534417 Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00534287 Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock Status COMPLETED Phase PHASE3
NCT00534222 Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect Status COMPLETED Phase N/A
NCT00533260 A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) Status COMPLETED Phase N/A
NCT00533169 ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma Status TERMINATED Phase PHASE1
NCT00532922 A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler® Status COMPLETED Phase N/A
NCT00532909 Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00532194 An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT00530699 Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) Status COMPLETED Phase PHASE1
NCT00528905 Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3